AIDX (AIDX)
0.27
0.00 (0.00%)
Upcoming Events
Latest Headlines
The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape
October 15, 2026 8:45 AM - StreetInsider
HEALWELL AI Named to TIME's World's Top HealthTech Companies of 2026 and Announces 12 Real-World Evidence and Clinical AI Presentations at International Conferences This Fall.
October 15, 2026 6:02 AM - StreetInsider
Form PRE 14A 20/20 Biolabs, Inc. For: Oct 06
October 6, 2026 4:33 PM - SEC Filing
HEALWELL AI Provides Research Update on Peer-Reviewed MyHealthNB Study and Global Recognition of DARWEN(TM)
October 6, 2026 6:02 AM - StreetInsider
20/20 BioLabs to Participate in the Maxim Growth Summit 2026 in New York on October 14, 2026
October 2, 2026 8:31 AM - StreetInsider
WELLSTAR Commences Trading on TSX Venture Exchange and Announces Its Board of Directors
October 1, 2026 6:02 AM - StreetInsider
20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise Model
September 29, 2026 8:31 AM - StreetInsider
HEALWELL AI to Present at the Cantech Investment Conference on October 8th in Toronto
September 28, 2026 4:02 PM - StreetInsider
HEALWELL Expands SMART Summary AI Deployment Across New Brunswick
September 23, 2026 6:02 AM - StreetInsider
Form 8-K 20/20 Biolabs, Inc. For: Sep 16
September 18, 2026 4:05 PM - SEC Filing
HEALWELL's DARWEN(TM) AI Outperforms Published Foundation Model Benchmarks and Demonstrates Real-World Patient Impact in New Peer-Reviewed Research
September 15, 2026 6:02 AM - StreetInsider
Form 8-K 20/20 Biolabs, Inc. For: Sep 03
September 10, 2026 4:11 PM - SEC Filing
Healwell's Darwen AI to match clinical trials to 100K+ consented patients
September 8, 2026 6:34 AM - StreetInsider
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
September 8, 2026 6:32 AM - StreetInsider
HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients
September 8, 2026 6:32 AM - StreetInsider
HEALWELL to Deploy AI-Powered SMART Search and SMART Summary Across Statewide U.S. Health Information Exchange
September 1, 2026 6:02 AM - StreetInsider
20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
August 28, 2026 6:26 PM - Globe NewsWire
20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
August 26, 2026 8:31 AM - StreetInsider
Form DEFA14A 20/20 Biolabs, Inc.
August 19, 2026 4:51 PM - SEC Filing
Form 8-K 20/20 Biolabs, Inc. For: Aug 18
August 19, 2026 9:19 AM - SEC Filing
Form 424B3 20/20 Biolabs, Inc.
August 17, 2026 4:15 PM - SEC Filing
Form 424B3 20/20 Biolabs, Inc.
August 17, 2026 4:10 PM - SEC Filing
Form 8-K 20/20 Biolabs, Inc. For: Aug 17
August 17, 2026 4:06 PM - SEC Filing
20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level
August 17, 2026 8:31 AM - StreetInsider
Form 10-Q 20/20 Biolabs, Inc. For: Jun 30
August 14, 2026 4:13 PM - SEC Filing
Form 8-K 20/20 Biolabs, Inc. For: Aug 05
August 5, 2026 12:01 PM - SEC Filing
20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour
July 30, 2026 8:31 AM - StreetInsider
20/20 BioLabs meets with East Asia partners to explore expansion
July 27, 2026 4:30 PM - StreetInsider
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy
July 27, 2026 4:30 PM - StreetInsider
20/20 BioLabs reaches standstill deal on Series E preferred stock
July 23, 2026 8:32 AM - StreetInsider
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock
July 23, 2026 8:31 AM - StreetInsider
Full Article List
